Aflibercept treat-and-extend regimen for neovascular AMD: 5-year outcomes
March 19th 2025The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading dose of a minimum of three monthly intravitreal aflibercept injections that was followed by a TAE.